Vaccine As a Platform (VaaP): Why the Future of Disease Eradication Needs to Be Data Driven
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Cotugno N, Ruggiero A, Santilli V, Manno E, Rocca S, Zicari S
. OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines. J Immunol Res. 2019; 2019:8732191.
PMC: 6512027.
DOI: 10.1155/2019/8732191.
View
2.
Dube E, Gagnon D, MacDonald N
. Strategies intended to address vaccine hesitancy: Review of published reviews. Vaccine. 2015; 33(34):4191-203.
DOI: 10.1016/j.vaccine.2015.04.041.
View
3.
Levitt T
. Marketing myopia. 1960. Harv Bus Rev. 2004; 82(7-8):138-49.
View
4.
Jones K, Laurie G, Stevens L, Dobbs C, Ford D, Lea N
. The other side of the coin: Harm due to the non-use of health-related data. Int J Med Inform. 2016; 97:43-51.
DOI: 10.1016/j.ijmedinf.2016.09.010.
View
5.
Dube E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J
. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013; 9(8):1763-73.
PMC: 3906279.
DOI: 10.4161/hv.24657.
View